Flutamide-induced hepatic dysfunction in relation to steady-state plasma concentrations of flutamide and its metabolites

This publication has 15 references indexed in Scilit:

• Clinical utility of ursodeoxycholic acid in preventing flutamide‐induced hepatopathy in patients with prostate cancer: A preliminary study
  International Journal of Urology, 2002
• [Flutamide-induced hepatic disorder and serum concentrations of flutamide and its metabolites in patients with prostate cancer].
  1999
• [Risk factor of liver disorders caused by flutamide--statistical analysis using multivariate logistic regression analysis].
  1999
• Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma
  Human & Experimental Toxicology, 1999
• Flutamide hepatotoxicity.
  1996
• Toxicity of the antiandrogen flutamide in isolated rat hepatocytes.
  1994
• Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
  The American Journal of Medicine, 1992
• Disposition of a New, Nonsteroid, Antiandrogen, α,α,α-Trifluoro-2-methyl-4′-nitro-m-propionotoluidide (Flutamide), in Men Following a single Oral 200 mg Dose
  Journal of Clinical Endocrinology & Metabolism, 1975
• Aspartate Aminotransferase and Alanine Aminotransferase Activities in Plasma: Statistical Distributions, Individual Variations, and Reference Values
  Clinical Chemistry, 1975
• The Present Status of Radical Prostatectomy for Stages A and B Prostatic Cancer
  Urologic Clinics of North America, 1975